Cargando…

Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?

[Image: see text] The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by solid form screening, but few forms readily grew high quality cryst...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Doris E., Lingireddy, Sreenivas R., Beidelschies, Mark D., Guo, Rui, Müller, Peter, Price, Sarah L., Reutzel-Edens, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629560/
https://www.ncbi.nlm.nih.gov/pubmed/29018305
http://dx.doi.org/10.1021/acs.cgd.7b00842
_version_ 1783269067371577344
author Braun, Doris E.
Lingireddy, Sreenivas R.
Beidelschies, Mark D.
Guo, Rui
Müller, Peter
Price, Sarah L.
Reutzel-Edens, Susan M.
author_facet Braun, Doris E.
Lingireddy, Sreenivas R.
Beidelschies, Mark D.
Guo, Rui
Müller, Peter
Price, Sarah L.
Reutzel-Edens, Susan M.
author_sort Braun, Doris E.
collection PubMed
description [Image: see text] The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by solid form screening, but few forms readily grew high quality crystals to afford a clear picture or understanding of the solid form landscape. Careful control of crystallization conditions, a range of experimental methods, computational modeling of solvate structures, and crystal structure prediction were required to see potential arrangements of the salt in its crystal forms. Structural diversity in the solid form landscape of B5HCl was apparent in the layer structures for the anhydrate polymorphs (Forms I and II), dihydrate and a family of solvates with alcohols. The alcohol solvates, which provided a distinct packing from the neat forms and the dihydrate, form layers with conserved hydrogen bonding between B5HCl and the solvent, as well as stacking of the aromatic rings. The ability of the alcohol hydrocarbon moieties to efficiently pack between the layers accounted for the difficulty in growing some solvate crystals and the inability of other solvates to crystallize altogether. Through a combination of experiment and computation, the crystallization problems, form stability, and desolvation pathways of B5HCl have been rationalized at a molecular level.
format Online
Article
Text
id pubmed-5629560
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-56295602017-10-08 Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few? Braun, Doris E. Lingireddy, Sreenivas R. Beidelschies, Mark D. Guo, Rui Müller, Peter Price, Sarah L. Reutzel-Edens, Susan M. Cryst Growth Des [Image: see text] The solid form landscape of 5-HT2a antagonist 3-(4-(benzo[d]isoxazole-3-yl)piperazin-1-yl)-2,2-dimethylpropanoic acid hydrochloride (B5HCl) proved difficult to establish. Many crystalline materials were produced by solid form screening, but few forms readily grew high quality crystals to afford a clear picture or understanding of the solid form landscape. Careful control of crystallization conditions, a range of experimental methods, computational modeling of solvate structures, and crystal structure prediction were required to see potential arrangements of the salt in its crystal forms. Structural diversity in the solid form landscape of B5HCl was apparent in the layer structures for the anhydrate polymorphs (Forms I and II), dihydrate and a family of solvates with alcohols. The alcohol solvates, which provided a distinct packing from the neat forms and the dihydrate, form layers with conserved hydrogen bonding between B5HCl and the solvent, as well as stacking of the aromatic rings. The ability of the alcohol hydrocarbon moieties to efficiently pack between the layers accounted for the difficulty in growing some solvate crystals and the inability of other solvates to crystallize altogether. Through a combination of experiment and computation, the crystallization problems, form stability, and desolvation pathways of B5HCl have been rationalized at a molecular level. American Chemical Society 2017-09-07 2017-10-04 /pmc/articles/PMC5629560/ /pubmed/29018305 http://dx.doi.org/10.1021/acs.cgd.7b00842 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Attribution (CC-BY) License (http://pubs.acs.org/page/policy/authorchoice_ccby_termsofuse.html) , which permits unrestricted use, distribution and reproduction in any medium, provided the author and source are cited.
spellingShingle Braun, Doris E.
Lingireddy, Sreenivas R.
Beidelschies, Mark D.
Guo, Rui
Müller, Peter
Price, Sarah L.
Reutzel-Edens, Susan M.
Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
title Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
title_full Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
title_fullStr Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
title_full_unstemmed Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
title_short Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
title_sort unraveling complexity in the solid form screening of a pharmaceutical salt: why so many forms? why so few?
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629560/
https://www.ncbi.nlm.nih.gov/pubmed/29018305
http://dx.doi.org/10.1021/acs.cgd.7b00842
work_keys_str_mv AT braundorise unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew
AT lingireddysreenivasr unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew
AT beidelschiesmarkd unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew
AT guorui unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew
AT mullerpeter unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew
AT pricesarahl unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew
AT reutzeledenssusanm unravelingcomplexityinthesolidformscreeningofapharmaceuticalsaltwhysomanyformswhysofew